Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10 clinical trials
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia

Objectives: To compare the efficacy and safety in children (<18 years) diagnosed as essential thrombocythemia treated with the Pegylated Interferon Alfa-2b vs. Interferon Alfa. Study Design: A prospective, open-label, nonrandomized, single-center clinical trial

essential thrombocythemia
peginterferon alfa-2b
interferon alfa
thrombocytosis
interferon
  • 0 views
  • 16 Feb, 2024
  • 1 location
The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

This is a phase III randomized, control, multi-center study of recombinant humanized anti-PD-1 mAb in combination with CTLA4 mAb for injection compared to high-Dose interferon in patients with acral melanoma that has been removed by surgery.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection

SNG001 is an inhaled drug that contains a antiviral protein called interferon beta (IFN-). IFN- in produced in the lungs during viral lung infections. It has been shown that older people and people with some chronic diseases have an IFN- deficiency.

lung disease
acute respiratory syndrome (sars)
antiviral drugs
interferon
asthma
  • 0 views
  • 01 Feb, 2023
  • 9 locations
Immunological Biomarkers in Tuberculosis Management

Investigators propose to evaluate the performance in terms of diagnosis accuracy and outcome prediction of four new biomarkers of active TB: 1) a double IGRA (Interferon Gamma Release Assay) including QuantiFERON-Gold Plus and HBHA; 2) a whole blood transcriptomic analysis of mRNA (messenger Ribonucleic acid) expression of a panel of …

immunophenotyping
interferon-gamma release assay
tuberculosis
antibiotics
interferon
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

This is a phase 2 study in which subjects with chronic hepatitis B virus (HBV) infection will receive VIR-2218 alone or in combination with pegylated interferon alfa-2a and will be assessed for safety, tolerability, pharmacokinetics, and antiviral activity.

antiviral drugs
interferon
hepatitis
chronic hepatitis
  • 0 views
  • 16 Feb, 2024
  • 18 locations
Tofacitinib for Immune Skin Conditions in Down Syndrome

Investigators will also measure the impact of interferon inhibition on a variety of molecular markers, as well as the cognitive abilities and quality of life of participants.

antibiotic therapy
atopic dermatitis
hair thinning
tofacitinib
disseminated herpes simplex
  • 0 views
  • 16 Feb, 2024
  • 1 location
Host-pathogen Interactions During SARS-CoV-2 Infection

Like some other coronaviruses (SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV)), these differences in clinical expression could be based on a variability in the immunological response, notably either via inhibition of the type I interferon (IFN-I) response, or on the contrary an immunological dysregulation responsible for a "cytokine storm" …

oxygen saturation
hypercytokinemia
acute respiratory syndrome (sars)
coronavirus infection
respiratory symptom
  • 0 views
  • 16 Feb, 2024
  • 12 locations
Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.

The purpose of this project is to realize a randomized open-label study (EudraCT number: 2020-000120-19) to evaluate the safety and the anti-tumor activity of peptide(s)-based immunotherapy in an umbrella window pre-operative opportunity phase II study in patients with squamous cell carcinoma of the head and neck.

head and neck carcinoma
cancer
skin cancer
platelet count
carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Early Environmental and Maternal Determinants of Airway Inflammation in Wheezing Disorders in Infants

This study collects data on microbiological, genetic and environmental factors, as well as lung function parameters (e.g. spirometry, body plethysmography, lung-MRI) to assess the complex interaction of predisposing risk factors for impaired lung development and respiratory diseases.

lung disease
social interactions
diabetes
social interaction
  • 0 views
  • 16 Feb, 2024
  • 1 location
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches

In light of the rapidly emerging pandemic of SARS-CoV-2 infections, the global population and health care systems are facing unprecedented challenges through the combination of transmission and the potential for severe disease. Acute respiratory distress syndrome (ARDS) has been found with unusual clinical features dominated by substantial alveolar fluid load. …

bronchoalveolar lavage
lower respiratory tract infection
acute respiratory syndrome (sars)
critical illness
pneumonia
  • 0 views
  • 16 Feb, 2024
  • 1 location